Botulinum toxin is a presynaptic neuromuscular blocking agent that, when injected intramuscularly in minute quantities, can produce selective muscle weakness. This property is employed therapeutically to provide symptomatic relief in conditions related to excessive muscle activities in strabismus, blepharospasm, hemifacial spasm, cervical dystonia, spasmodic dysphonia (adductor type), and jaw closing dystonia. It is investigational for a long list of medical conditions. It is a marketed drug in a number of countries in the world, but its use has only been approved by different regulatory agencies for use in a limited number of conditions. The long-term effects, appropriate dose for children, and in pregnancy, and maximum dose without causing toxicity remain unclear. Copyright (C) 1996 Elsevier Science Inc.
机构:
Allergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USAAllergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USA
Aoki, KR
Ismail, M
论文数: 0引用数: 0
h-index: 0
机构:
Allergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USAAllergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USA
Ismail, M
Tang-Liu, D
论文数: 0引用数: 0
h-index: 0
机构:
Allergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USAAllergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USA
Tang-Liu, D
Brar, B
论文数: 0引用数: 0
h-index: 0
机构:
Allergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USAAllergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USA
Brar, B
Wheeler, LA
论文数: 0引用数: 0
h-index: 0
机构:
Allergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USAAllergan Pharmaceut Inc, Neurotoxin Res Programme Team, Irvine, CA 92713 USA